Research Progress on the Anticancer Molecular Mechanism of Targets Regulating Cell Autophagy

Ting Zhang1,2, Jia Yu1,3, Sha Cheng1,3

  • 1State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China.

Pharmacology
|March 8, 2023
PubMed
Abstract

Insights

Autophagy, a cellular process, plays a dual role in cancer, influencing cell survival and drug resistance. Targeting autophagy with natural compounds offers a promising strategy for developing novel anticancer therapies.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Autophagy is a fundamental cellular process crucial for maintaining homeostasis and survival in both normal and tumor cells.
  • Dysregulated autophagy is implicated in aging, neurodegeneration, infectious diseases, immune disorders, and cancer development.
  • Autophagy exhibits a dual role in cancer, impacting cell survival, proliferation, death, and chemotherapy resistance.

Purpose of the Study:

  • To elucidate the intricate mechanism of autophagy.
  • To review the multifaceted role of autophagy in normal and cancerous cells.
  • To summarize research on the anticancer molecular mechanisms of autophagy-regulating targets.

Main Methods:

  • Literature review of autophagy mechanisms.
  • Analysis of autophagy's role in normal and cancer cells.
  • Synthesis of research on autophagy-targeting anticancer strategies.

Main Results:

  • Autophagy's dual role in cancer progression and treatment response is highlighted.
  • Natural products and their derivatives show potential in modulating autophagy for anticancer effects.
  • Regulation of autophagy presents a viable strategy for enhancing tumor therapy.

Conclusions:

  • Understanding autophagy's mechanism and role is key to cancer research.
  • Developing autophagy modulators (inhibitors or activators) can improve anticancer efficacy.
  • Natural product-derived small molecules offer a promising avenue for autophagy-based cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K